Availability of 25-hydroxyvitamin D3 to APCs controls the balance between regulatory and inflammatory T cell responses

Journal of Immunology

Volumn 189, Issue 11, 2012, Pages 5155-5164

  Jeffery, Louisa E ^a   Wood, Alice M ^a   Qureshi, Omar S ^a   Hou, Tie Zheng ^a   Gardner, David ^a   Briggs, Zoe ^a   Kaur, Satdip ^a   Raza, Karim ^a,b   Sansom, David M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CYTOCHROME P450; LIPOPOLYSACCHARIDE; PROTEIN CYP27B1; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ANTIGEN PRESENTING CELL; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; PRIORITY JOURNAL;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CALCIFEDIOL; CALCITRIOL; CELL COMMUNICATION; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENZYME ACTIVATION; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84869815306     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200786     Document Type: Article

References (65)

1. Hewison, M. 2012. Vitamin D and immune function: an overview. Proc. Nutr. Soc. 71: 50-61.
2. Holick, M. F. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266-281.
3. Hanwell HE, Banwell B. 2011. Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim. Biophys. Acta. 1812: 202-212.
4. Mowry, E. M. 2011. Vitamin D: evidence for its role as a prognostic factor in multiple sclerosis. J. Neurol. Sci. 311: 19-22.
5. Cutolo, M., C. Pizzorni, and A. Sulli. 2011. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun. Rev. 11: 84-87.
6. Hyppönen, E. 2010. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association? Diabetes Obes. Metab. 12: 737-743.
7. Raman, M., A. N. Milestone, J. R. Walters, A. L. Hart, and S. Ghosh. 2011. Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Therap Adv Gastroenterol 4: 49-62.
8. Adorini, L., and G. Penna. 2008. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4: 404-412.
9. Baeke, F., T. Takiishi, H. Korf, C. Gysemans, and C. Mathieu. 2010. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10: 482-496.
10. Cantorna, M. T. 2012. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch. Biochem. Biophys. 523: 103-106.
11. Cross, H. S., T. Nittke, and E. Kallay. 2011. Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer. Mol. Cell. Endocrinol. 347: 70-79.
12. Larsson, P., L. Mattsson, L. Klareskog, and C. Johnsson. 1998. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin. Exp. Immunol. 114: 277-283. (Pubitemid 28505730)
13. Mayne, C. G., J. A. Spanier, L. M. Relland, C. B. Williams, and C. E. Hayes. 2011. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur. J. Immunol. 41: 822-832.
14. Berer, A., J. Stöckl, O. Majdic, T. Wagner, M. Kollars, K. Lechner, K. Geissler, and L. Oehler. 2000. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol. 28: 575-583. (Pubitemid 30254459)
15. Canning, M. O., K. Grotenhuis, H. de Wit, C. Ruwhof, and H. A. Drexhage. 2001. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 145: 351-357. (Pubitemid 32825669)
16. Penna, G., and L. Adorini. 2000. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411. (Pubitemid 30115468)
17. Barrat, F. J., D. J. Cua, A. Boonstra, D. F. Richards, C. Crain, H. F. Savelkoul, R. de Waal-Malefyt, R. L. Coffman, C. M. Hawrylowicz, and A. O'Garra. 2002. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J. Exp. Med. 195: 603-616. (Pubitemid 34461505)
18. Colin, E. M., P. S. Asmawidjaja, J. P. van Hamburg, A. M. Mus, M. van Driel, J. M. Hazes, J. P. van Leeuwen, and E. Lubberts. 2010. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 62: 132-142.
19. Ikeda, U., D. Wakita, T. Ohkuri, K. Chamoto, H. Kitamura, Y. Iwakura, and T. Nishimura. 2010. 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol. Lett. 134: 7-16.
20. Jeffery, L. E., F. Burke, M. Mura, Y. Zheng, O. S. Qureshi, M. Hewison, L. S. Walker, D. A. Lammas, K. Raza, and D. M. Sansom. 2009. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183: 5458-5467.
21. Urry, Z., E. Xystrakis, D. F. Richards, J. McDonald, Z. Sattar, D. J. Cousins, C. J. Corrigan, E. Hickman, Z. Brown, and C. M. Hawrylowicz. 2009. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25- dihydroxyvitamin D3 abrogates regulatory function. J. Clin. Invest. 119: 387-398.
22. Hewison, M., F. Burke, K. N. Evans, D. A. Lammas, D. M. Sansom, P. Liu, R. L. Modlin, and J. S. Adams. 2007. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 103: 316-321. (Pubitemid 46420518)
23. Zehnder, D., R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison. 2001. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 86: 888-894. (Pubitemid 32207511)
24. Fritsche, J., K. Mondal, A. Ehrnsperger, R. Andreesen, and M. Kreutz. 2003. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 102: 3314-3316. (Pubitemid 37314772)
25. Adams, J. S., O. P. Sharma, M. A. Gacad, and F. R. Singer. 1983. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest. 72: 1856-1860. (Pubitemid 14229067)
26. Nykjaer, A., D. Dragun, D. Walther, H. Vorum, C. Jacobsen, J. Herz, F. Melsen, E. I. Christensen, and T. E. Willnow. 1999. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507-515. (Pubitemid 29106838)
27. Rowling, M. J., C. M. Kemmis, D. A. Taffany, and J. Welsh. 2006. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxy-cholecalciferol actions in human mammary cells. J. Nutr. 136: 2754-2759. (Pubitemid 44771769)
28. Atkins, G. J., P. H. Anderson, D. M. Findlay, K. J. Welldon, C. Vincent, A. C. Zannettino, P. D. O'Loughlin, and H. A. Morris. 2007. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone 40: 1517-1528. (Pubitemid 46756427)
29. Arnaud, J., and J. Constans. 1993. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum. Genet. 92: 183-188. (Pubitemid 23272286)
30. Wood, A. M., C. Bassford, D. Webster, P. Newby, P. Rajesh, R. A. Stockley, and D. R. Thickett. 2011. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax 66: 205-210.
31. Martineau, A. R., A. C. Leandro, S. T. Anderson, S. M. Newton, K. A. Wilkinson, M. P. Nicol, S. M. Pienaar, K. H. Skolimowska, M. A. Rocha, V. C. Rolla, et al. 2010. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur. Respir. J. 35: 1106-1112.
32. Papiha, S. S., and B. Pal. 1985. Gc (vitamin D binding protein) subtypes in rheumatoid arthritis. Hum. Genet. 70: 278-280. (Pubitemid 15234386)
33. Speeckaert, M., G. Huang, J. R. Delanghe, and Y. E. Taes. 2006. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta 372: 33-42. (Pubitemid 44286753)
34. Wood, A. M., M. J. Simmonds, D. L. Bayley, P. R. Newby, S. C. Gough, and R. A. Stockley. 2008. The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency. Respir. Res. 9: 52.
35. Baeke, F., H. Korf, L. Overbergh, E. van Etten, A. Verstuyf, C. Gysemans, and C. Mathieu. 2010. Human T lymphocytes are direct targets of 1,25-dihydroxy-vitamin D3 in the immune system. J. Steroid Biochem. Mol. Biol. 121: 221-227.
36. Correale, J., M. Cl. Ysrraelit, and M. I. Gaitán. 2009. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132: 1146-1160.
37. Sigmundsdottir, H., J. Pan, G. F. Debes, C. Alt, A. Habtezion, D. Soler, and E. C. Butcher. 2007. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8: 285-293. (Pubitemid 46745378)
38. Bikle, D. D., S. Pillai, E. Gee, and M. Hincenbergs. 1989. Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 124: 655-660. (Pubitemid 19057051)
39. Bikle, D. D., S. Pillai, E. Gee, and M. Hincenbergs. 1991. Tumor necrosis factoralpha regulation of 1,25-dihydroxyvitamin D production by human keratinocytes. Endocrinology 129: 33-38.
40. Edfeldt, K., P. T. Liu, R. Chun, M. Fabri, M. Schenk, M. Wheelwright, C. Keegan, S. R. Krutzik, J. S. Adams, M. Hewison, and R. L. Modlin. 2010. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. USA 107: 22593-22598.
41. Gyetko, M. R., C. H. Hsu, C. C. Wilkinson, S. Patel, and E. Young. 1993. Monocyte 1 alpha-hydroxylase regulation: induction by inflammatory cytokines and suppression by dexamethasone and uremia toxin. J. Leukoc. Biol. 54: 17-22. (Pubitemid 23274617)
42. Krutzik, S. R., M. Hewison, P. T. Liu, J. A. Robles, S. Stenger, J. S. Adams, and R. L. Modlin. 2008. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181: 7115-7120.
43. Stoffels, K., L. Overbergh, A. Giulietti, L. Verlinden, R. Bouillon, and C. Mathieu. 2006. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J. Bone Miner. Res. 21: 37-47. (Pubitemid 43023225)
44. van Driel, M., M. Koedam, C. J. Buurman, M. Hewison, H. Chiba, A. G. Uitterlinden, H. A. Pols, and J. P. van Leeuwen. 2006. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J. 20: 2417-2419.
45. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
46. Chun, R. F., A. L. Lauridsen, L. Suon, L. A. Zella, J. W. Pike, R. L. Modlin, A. R. Martineau, R. J. Wilkinson, J. Adams, and M. Hewison. 2010. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxy-vitamin D. J. Clin. Endocrinol. Metab. 95: 3368-3376.
47. Adams, J. S., S. Ren, P. T. Liu, R. F. Chun, V. Lagishetty, A. F. Gombart, N. Borregaard, R. L. Modlin, and M. Hewison. 2009. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol. 182: 4289-4295.
48. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764. (Pubitemid 47236314)
49. Cantorna, M. T. 2008. Vitamin D and multiple sclerosis: an update. Nutr. Rev. 66 (Suppl 2): S135-S138.
50. Merlino, L. A., J. Curtis, T. R. Mikuls, J. R. Cerhan, L. A. Criswell, and K. G. Saag; Iowa Women's Health Study. 2004. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 50: 72-77. (Pubitemid 38084289)
51. Pappa, H. M., C. M. Gordon, T. M. Saslowsky, A. Zholudev, B. Horr, M. C. Shih, and R. J. Grand. 2006. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118: 1950-1961. (Pubitemid 46393676)
52. Vagianos, K., S. Bector, J. McConnell, and C. N. Bernstein. 2007. Nutrition assessment of patients with inflammatory bowel disease. JPEN J. Parenter. Enteral Nutr. 31: 311-319. (Pubitemid 47025695)
53. Powe, C. E., C. Ricciardi, A. H. Berg, D. Erdenesanaa, G. Collerone, E. Ankers, J. Wenger, S. A. Karumanchi, R. Thadhani, and I. Bhan. 2011. Vitamin Dbinding protein modifies the vitamin D-bone mineral density relationship. J. Bone Miner. Res. 26: 1609-1616.
54. McLeod, J. F., M. A. Kowalski, and J. G. Haddad. 1986. Characterization of a monoclonal antibody to human serum vitamin D binding protein (Gc globulin): recognition of an epitope hidden in membranes of circulating monocytes. Endocrinology 119: 77-83. (Pubitemid 16100710)
55. Kew, R. R., M. A. Sibug, J. P. Liuzzo, and R. O. Webster. 1993. Localization and quantitation of the vitamin D binding protein (Gc-globulin) in human neutrophils. Blood 82: 274-283. (Pubitemid 23188774)
56. Machii, T., H. Kimura, E. Ueda, T. Chujo, T. Morita, S. Katagiri, S. Tagawa, and T. Kitani. 1986. Distribution of Gc protein (vitamin D binding protein) on the surfaces of normal human lymphocytes and leukemic lymphocytes. Acta Haematol. 75: 26-29. (Pubitemid 16095357)
57. Petrini, M., A. Allegrini, F. Ambrogi, P. Valentini, A. Sabbatini, P. Arnaud, and R. M. Galbraith. 1995. Binding of GC (VDBP) to membranes of human B lymphocytes following stripping of extant protein. J. Endocrinol. Invest. 18: 630-637.
58. Correale, J., M. C. Ysrraelit, and M. I. Gaitán. 2010. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J. Immunol. 185: 4948-4958.
59. Bouillon, R., D. Z. Xiang, R. Convents, and H. Van Baelen. 1992. Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding protein. J. Steroid Biochem. Mol. Biol. 42: 855-861.
60. Calvo, M., and J. M. Ena. 1989. Relations between vitamin D and fatty acid binding properties of vitamin D-binding protein. Biochem. Biophys. Res. Commun. 163: 14-17. (Pubitemid 19227262)
61. Ramagopalan, S. V., A. Heger, A. J. Berlanga, N. J. Maugeri, M. R. Lincoln, A. Burrell, L. Handunnetthi, A. E. Handel, G. Disanto, S. M. Orton, et al. 2010. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 20: 1352-1360.
62. Qureshi, O. S., Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti, E. M. Schmidt, J. Baker, L. E. Jeffery, S. Kaur, Z. Briggs, et al. 2011. Transendocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332: 600-603.
63. Walker, L. S., and D. M. Sansom. 2011. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat. Rev. Immunol. 11: 852-863.
64. Zheng, Y., C. N. Manzotti, F. Burke, L. Dussably, O. Qureshi, L. S. Walker, and D. M. Sansom. 2008. Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol. 181: 1683-1691.
65. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.